To elucidate the involvement of increased SCFA abundance in the anti-metabolic syndrome effects of GCL2505, we assessed the effects of GCL2505 on metabolic parameters and SCFA levels in Gpr43−/− and wild type (WT) mice. This evidence concerns the gene FFAR2 and metabolic syndrome.